English

Diabetes

Europe in Motion

Where in Europe is diabetes most prevalent?

ADVERTISEMENT

ADVERTISEMENT

More about this topic

Economy

The Ozempic ripple: When a single jab moves an entire market

As GLP-1 use spreads, grocers and restaurants see lighter baskets, airlines predict fuel savings and health systems eye lower costs—while Denmark sees a clipped GDP.

Health news

Eli Lilly’s daily weight loss pill succeeds in latest trial

Lilly said it plans to ask regulators to approve the drug by the end of 2025.

Health news

Portugal limits weight loss drug prescriptions to prevent misuse

Doctors from only four medical specialties will be able to write prescriptions for injectable drugs that are used to treat type 2 diabetes and obesity but are also popular for weight loss.

Culture news

Supermodel Lila Moss launches first Barbie doll with type 1 diabetes

Fashion for some will always come first but by introducing the first Barbie doll with type 1 diabetes, Mattel are showing, once again, that the world of child's play can be a space for the true representation of different social groups.

ADVERTISEMENT

Culture news

Cause of death for Buffy actress Michelle Trachtenberg revealed

NYC medical examiner has said the 39-year-old actress died as a result of complications from diabetes.

Health news

1 in 5 UK adults estimated to have diabetes in new record high

More than 1 million adults in the UK have type 2 diabetes but have not been diagnosed, according to the newly-released report.

Business

Eli Lilly shares rise as Zepbound weight-loss test shows solid success

Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The drug maker also said more patients taking Zepbound achieved at least 25% weight loss.

Health news

Over 800 million people have diabetes globally. What about in Europe?

Diabetes rates have doubled globally in the last three decades, a new study suggests, here’s what to know about the situation in Europe.

Health news

Weight-loss drugs like Ozempic may reduce opioid overdose rates

A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in people with opioid and alcohol use disorders.

wellbeing

Intense weekend exercise may have similar benefits to regular workouts

Both regular exercise and intense weekend exercise were found to lower the risk of more than 200 diseases, including hypertension and diabetes.

Business

Novo Nordisk boss in US grilling over prices for weight-loss drugs

Novo Nordisk has been criticised by US politicians for the high pricing of its popular weight-loss and diabetes drugs. But CEO Lars Fruergaard Jørgensen has defended the company, attributing the elevated prices to "structural issues" within the US healthcare system.

Health news

Insulin resistance linked to risk of over 30 diseases and early death

A recent study found that insulin resistance is associated with an increased risk of 26 conditions, a lower risk of five more, and early death in women.

Business

Novo Nordisk: Earnings trimmed as rivals seek to enter market

Novo Nordisk missed earnings expectations in the second quarter due to growing competition and increased costs from capacity expansions. The company also downgraded its profit outlook for 2024.

Health news

Diabetes-reversing treatment boosts insulin-producing cells by 700%

A new preclinical study found a combination treatment that significantly increases insulin-producing cells, effectively reversing diabetes.

Business

Wegovy and Ozempic maker Novo Nordisk plans billion-dollar US plant

Novo Nordisk announces a plan to invest $4.1 billion to expand its capacity of making weight loss drug Wegovy and diabetes treatment Ozempic.

Health news

Intermittent fasting may help type 2 diabetics control blood sugar

A new study found that intermittent fasting may be an effective initial intervention for type 2 diabetics instead of medication.

Business

Novo Nordisk beats Q1 estimates as weight-loss drugs drive growth

Danish pharmaceutical titan Novo Nordisk, the maker of Ozempic and Wegovy, announces a significant year-over-year increase in net profit and sales for the first quarter of 2024.

Health news

Oral insulin could replace injections for diabetics, new study finds

A new form of oral insulin, which may soon be tested in humans, can be taken as an alternative to syringes or insulin pumps.

Nutrition

Glucose monitors are gaining popularity among those without diabetes

This stick-on arm patch is among the new generation of glucose monitors.

Health news

Americans turn to alternatives amid Ozempic shortage

Approved in 2017 for adults with type 2 diabetes, Ozempic has now become a blockbuster weight loss drug.